{"id":60221,"date":"2024-02-28T06:39:05","date_gmt":"2024-02-28T06:39:05","guid":{"rendered":"https:\/\/medsname.com\/primaquine\/"},"modified":"2026-04-30T10:23:49","modified_gmt":"2026-04-30T10:23:49","slug":"primaquine","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/primaquine\/","title":{"rendered":"Primaquin"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8d6;border-left:4px solid #f5c518;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<h3 style=\"margin-top:0;\">Rychl\u00e1 odpov\u011b\u010f<\/h3>\n<p><strong>Primaquin<\/strong> obsahuje <strong>primaquin phosphate 15 mg base<\/strong> (Sanofi India). Je to jedin\u00fd \u0161iroce dostupn\u00fd l\u00e9k schopn\u00fd <strong>radik\u00e1ln\u00ed l\u00e9\u010dby P. vivax a P. ovale recidivuj\u00edc\u00ed mal\u00e1rie<\/strong> \u2014 zab\u00edj\u00ed dormantn\u00ed <em>hypnozoity<\/em> jatern\u00ed st\u00e1dium, kter\u00e9 ostatn\u00ed antimalarika neovliv\u0148uj\u00ed. Standardn\u00ed re\u017eim: <strong>30 mg base\/den po dobu 14 dn\u016f<\/strong> po 3denn\u00edm cyklu chlorochinu, kter\u00fd vy\u010dist\u00ed krevn\u00ed st\u00e1dium. Tak\u00e9 se pou\u017e\u00edv\u00e1 pro <em>P. falciparum<\/em> vy\u010di\u0161t\u011bn\u00ed gametocyt\u016f (jednor\u00e1zov\u00e1 d\u00e1vka 0,25 mg\/kg, blokuj\u00edc\u00ed p\u0159enos) a jako mo\u017enost pro <em>Pneumocystis jirovecii<\/em> z\u00e1pal plic u pacient\u016f alergick\u00fdch na sulfonamidy (s klindamycinem). <strong>Povinn\u00e9 testov\u00e1n\u00ed G6PD p\u0159ed pou\u017eit\u00edm<\/strong> \u2014 primachin zp\u016fsobuje t\u011b\u017ekou hemolytickou an\u00e9mii u pacient\u016f s deficitem G6PD. U\u017e\u00edvejte s j\u00eddlem ke sn\u00ed\u017een\u00ed gastrointestin\u00e1ln\u00edch pot\u00ed\u017e\u00ed.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f4f4;border:1px solid #e0e0e0;border-radius:6px;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.5;\"><strong>\ud83c\udfed V\u00fdrobce certifikovan\u00fd WHO-GMP<\/strong> &nbsp;\u00b7&nbsp; <strong>\ud83d\udce6 Diskr\u00e9tn\u00ed balen\u00ed<\/strong> &nbsp;\u00b7&nbsp; <strong>\ud83c\udf0d Doprava do cel\u00e9ho sv\u011bta<\/strong> &nbsp;\u00b7&nbsp; <strong>\u2b50 <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">1,400+ recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/strong><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:13px;color:#555;margin:10px 0 18px;\">\ud83d\udee1\ufe0f Ka\u017ed\u00e1 objedn\u00e1vka je kryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, za\u0161leme zdarma n\u00e1hradn\u00ed z\u00e1silku prost\u0159ednictv\u00edm kur\u00fdrn\u00ed slu\u017eby EMS nebo ITPS.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Primachin je z\u00edsk\u00e1v\u00e1n od v\u00fdrobce certifikovan\u00e9ho WHO-GMP a expedov\u00e1n po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm balen\u00ed. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a> a podporov\u00e1na na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">1,400+ recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>.  . Celosv\u011btov\u00e1 doprava bez p\u0159edpisov\u00e9 dokumentace.<\/p>\n<h2>O Primachinu<\/h2>\n<p>Primachin je tableta obsahuj\u00edc\u00ed 15 mg primachin fosf\u00e1tu (b\u00e1ze) vyr\u00e1b\u011bn\u00e1 spole\u010dnost\u00ed Sanofi India za podm\u00ednek certifikovan\u00fdch WHO-GMP. Primachin je 8-aminochinolin poprv\u00e9 vyvinut\u00fd americkou arm\u00e1dou b\u011bhem druh\u00e9 sv\u011btov\u00e9 v\u00e1lky. Je na seznamu z\u00e1kladn\u00edch l\u00e9k\u016f WHO a z\u016fst\u00e1v\u00e1 jedin\u00fdm \u0161iroce dostupn\u00fdm l\u00e9kem, kter\u00fd zab\u00edj\u00ed dormantn\u00ed hypnozoitn\u00ed jatern\u00ed st\u00e1dium <em>P. vivax<\/em> a <em>P. ovale<\/em> \u2014 bez l\u00e9\u010dby primachinem mohou tito parazit\u00e9 relapsovat t\u00fddny a\u017e m\u011bs\u00edce po l\u00e9\u010db\u011b krevn\u00edho st\u00e1dia.<\/p>\n<h2>Jak primachin funguje<\/h2>\n<p>P\u0159esn\u00fd molekul\u00e1rn\u00ed c\u00edl primachinu nen\u00ed zcela charakterizov\u00e1n \u2014 vedouc\u00ed hypot\u00e9za je, \u017ee jeden z jeho metabolit\u016f generovan\u00fdch CYP2D6 vytv\u00e1\u0159\u00ed reaktivn\u00ed kysl\u00edkov\u00e9 species a voln\u00e9 radik\u00e1ly, kter\u00e9 po\u0161kozuj\u00ed mitochondri\u00e1ln\u00ed membr\u00e1nu parazita v jatern\u00edm st\u00e1diu hypnozoitu. Stejn\u00e1 oxida\u010dn\u00ed chemie je to, co po\u0161kozuje \u010derven\u00e9 krvinky s deficitem G6PD (kde redukovan\u00fd glutathion nem\u016f\u017ee regenerovat, aby neutralizoval oxida\u010dn\u00ed stres) \u2014 co\u017e vysv\u011btluje paralelu mezi antiparazit\u00e1rn\u00ed aktivitou primachinu a jeho hemolytickou toxicitou.<\/p>\n<p>Primachin m\u00e1 slabou aktivitu na parazity v krevn\u00edm st\u00e1diu \u2014 kombinujte jej s chlorochinem (v oblastech citliv\u00fdch na chlorochin u vivax\/ovale) nebo s artemisininovou kombinovanou terapi\u00ed k nejprve vy\u010di\u0161t\u011bn\u00ed krevn\u00edho st\u00e1dia. Samotn\u00fd primachin NEN\u00cd l\u00e9\u010dbou akutn\u00ed symptomatick\u00e9 mal\u00e1rie.<\/p>\n<h2>Indikace a d\u00e1vkov\u00e1n\u00ed<\/h2>\n<div style=\"overflow-x:auto;margin:18px 0;\">\n<table style=\"width:100%;border-collapse:collapse;font-size:14px;\">\n<thead>\n<tr>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">Indikace<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">D\u00e1vkov\u00e1n\u00ed (v mg b\u00e1ze)<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">Pozn\u00e1mky<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Radik\u00e1ln\u00ed l\u00e9\u010dba P. vivax \/ P. ovale (norm\u00e1ln\u00ed G6PD)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">30 mg base\/den po dobu 14 dn\u016f<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Po l\u00e9\u010db\u011b krevn\u00edho st\u00e1dia chlorochinem (nebo ACT). Dodr\u017eov\u00e1n\u00ed v\u0161ech 14 dn\u016f je nezbytn\u00e9 \u2014 p\u0159ed\u010dasn\u00e9 ukon\u010den\u00ed je nej\u010dast\u011bj\u0161\u00ed p\u0159\u00ed\u010dinou relapsu.<\/td>\n<\/tr>\n<tr style=\"\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">P. vivax u tropick\u00fdch\/oce\u00e1nsk\u00fdch kmen\u016f (Chesson-like, n\u00e1chyln\u011bj\u0161\u00ed k relapsu)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">30 mg b\u00e1ze\/den po 14 dn\u00ed, n\u011bkdy prodlou\u017eeno na 21 dn\u00ed dle uv\u00e1\u017een\u00ed specialisty<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Vy\u0161\u0161\u00ed kumulativn\u00ed d\u00e1vka pro kmeny rezistentn\u00ed na chlorochin nebo bohat\u00e9 na hypnozoity.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Radik\u00e1ln\u00ed l\u00e9\u010dba P. vivax (st\u0159edn\u00ed G6PD)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">0,75 mg\/kg jednou t\u00fddn\u011b \u00d7 8 t\u00fddn\u016f<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Pod dohledem specialisty. Vy\u017eaduje hematologick\u00e9 sledov\u00e1n\u00ed.<\/td>\n<\/tr>\n<tr style=\"\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Odstran\u011bn\u00ed gametocyt\u016f P. falciparum (blokov\u00e1n\u00ed p\u0159enosu, n\u00edzk\u00e1 dle WHO)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">0,25 mg\/kg jednor\u00e1zov\u00e1 d\u00e1vka s ACT<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">I u pacient\u016f s deficitem G6PD je riziko hemol\u00fdzy p\u0159i t\u00e9to jednor\u00e1zov\u00e9 d\u00e1vce n\u00edzk\u00e9.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Pneumocystis jirovecii pneumonie (PJP) \u2014 alternativa k TMP-SMX p\u0159i alergii na sulfonamidy<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">30 mg b\u00e1ze\/den s klindamycinem 600 mg peror\u00e1ln\u011b 3\u00d7 denn\u011b po dobu 21 dn\u00ed<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Specializovan\u00fd kontext HIV \/ imunokompromitovan\u00e9ho hostitele.<\/td>\n<\/tr>\n<tr style=\"\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Radik\u00e1ln\u00ed l\u00e9\u010dba vivaxu u d\u011bt\u00ed (\u2265 6 m\u011bs\u00edc\u016f, norm\u00e1ln\u00ed G6PD)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">0,5 mg\/kg\/den po dobu 14 dn\u00ed (max. 30 mg\/den)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">M\u016f\u017ee b\u00fdt nutn\u00e9 rozd\u011blen\u00ed tablet.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.6;\"><strong>G6PD \u010derven\u00fd r\u00e1me\u010dek \u2014 povinn\u00e9 p\u0159ed pou\u017eit\u00edm.<\/strong> Primachin zp\u016fsobuje t\u011b\u017ekou akutn\u00ed hemolytickou an\u00e9mii u pacient\u016f s deficitem G6PD. <strong>P\u0159ed p\u0159edeps\u00e1n\u00edm vy\u0161et\u0159ete stav G6PD<\/strong>. Standardn\u00ed fluorescen\u010dn\u00ed spot test nebo kvantitativn\u00ed test je p\u0159ijateln\u00fd. <strong>T\u011b\u017ek\u00fd deficit G6PD (&lt; 30 % aktivity)<\/strong> \u2014 primachin kontraindikov\u00e1n; pou\u017eijte tafenoquin (jin\u00fd 8-aminochinolin, jednor\u00e1zov\u00e1 d\u00e1vka, tak\u00e9 omezen\u00fd pro G6PD) nebo alternativn\u00ed strategii. <strong>St\u0159edn\u00ed deficit G6PD (heterozygotn\u00ed \u017eeny 30\u201370 %)<\/strong> \u2014 rozhodnut\u00ed p\u0159\u00edpad od p\u0159\u00edpadu; n\u011bkter\u00e9 autority pou\u017e\u00edvaj\u00ed upraven\u00fd t\u00fddenn\u00ed re\u017eim (0,75 mg\/kg jednou t\u00fddn\u011b \u00d7 8 t\u00fddn\u016f) pod hematologick\u00fdm dohledem. T\u011b\u017ek\u00e1 hemol\u00fdza se projevuje tmavou\/barvou koly mo\u010di, \u017eloutenkou, bledost\u00ed, \u00fanavou, du\u0161nost\u00ed \u2014 okam\u017eit\u011b p\u0159eru\u0161te pod\u00e1v\u00e1n\u00ed l\u00e9ku a vyhledejte l\u00e9ka\u0159sk\u00e9 vy\u0161et\u0159en\u00ed. Prevalence G6PD je 5\u201310 % v mnoha africk\u00fdch, st\u0159edomo\u0159sk\u00fdch, indick\u00fdch, bl\u00edzkov\u00fdchodn\u00edch a jihov\u00fdchodn\u00edch asijsk\u00fdch populac\u00edch a v\u00fdrazn\u011b vy\u0161\u0161\u00ed v n\u011bkter\u00fdch subpopulac\u00edch (a\u017e 25 % u sardinsk\u00fdch nebo kurdsk\u00fdch mu\u017e\u016f).<\/div>\n<h2>Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<ul>\n<li><strong>\u010cast\u00e9 (5\u201315 %):<\/strong> nevolnost, b\u0159i\u0161n\u00ed k\u0159e\u010de, bolest hlavy, z\u00e1vrat\u011b \u2014 t\u00e9m\u011b\u0159 v\u0161echny p\u0159\u00edznaky lze zm\u00edrnit pod\u00e1v\u00e1n\u00edm s j\u00eddlem.<\/li>\n<li><strong>M\u00e9n\u011b \u010dast\u00e9:<\/strong> m\u00edrn\u00e1 methemoglobin\u00e9mie (cyan\u00f3za p\u0159i vysok\u00fdch d\u00e1vk\u00e1ch, zejm\u00e9na u pacient\u016f s deficitem NADH cytochromu b5 redukt\u00e1zy), sv\u011bd\u011bn\u00ed, leukopenie, an\u00e9mie.<\/li>\n<li><strong>T\u011b\u017ek\u00e9 (u pacient\u016f s deficitem G6PD):<\/strong> akutn\u00ed intravaskul\u00e1rn\u00ed hemolytick\u00e1 an\u00e9mie projevuj\u00edc\u00ed se tmavou mo\u010d\u00ed, \u017eloutenkou, \u00fanavou, bledost\u00ed, du\u0161nost\u00ed \u2014 p\u0159eru\u0161te l\u00e9\u010dbu a okam\u017eit\u011b vyhledejte l\u00e9ka\u0159sk\u00e9 vy\u0161et\u0159en\u00ed.<\/li>\n<li><strong>Vz\u00e1cn\u00e9:<\/strong> t\u011b\u017ek\u00e1 methemoglobin\u00e9mie, agranulocyt\u00f3za, hypertenze.<\/li>\n<\/ul>\n<h2>Interakce l\u00e9k\u016f<\/h2>\n<div style=\"overflow-x:auto;margin:18px 0;\">\n<table style=\"width:100%;border-collapse:collapse;font-size:14px;\">\n<thead>\n<tr>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">Interakce<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">\u00da\u010dinek<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px;text-align:left;\">\u0158e\u0161en\u00ed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Chinakrin<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Zvy\u0161uje toxicitu primachinu<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Vyhn\u011bte se kombinaci \u2013 historick\u00fd probl\u00e9m, v modern\u00ed praxi se vyskytuje z\u0159\u00eddka.<\/td>\n<\/tr>\n<tr style=\"\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Dal\u0161\u00ed l\u00e9ky vyvol\u00e1vaj\u00edc\u00ed hemol\u00fdzu (dapson, sulfonamidy, nitrofurantoin u G6PD)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Aditivn\u00ed hemol\u00fdza<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Vyhn\u011bte se kombinaci u pacient\u016f s deficitem G6PD.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">L\u00e9ky vyvol\u00e1vaj\u00edc\u00ed methemoglobinemii (dapson, nitrity)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Aditivn\u00ed methemoglobinemie<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Sledujte hladinu methemoglobinu; vyhn\u011bte se kombinaci.<\/td>\n<\/tr>\n<tr style=\"\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Antiretrovirotika (tenofovir, zidovudin, efavirenz)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">\u017d\u00e1dn\u00e1 klinicky v\u00fdznamn\u00e1 interakce<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Kombinace je bezpe\u010dn\u00e1.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Inhibitory CYP2D6 (fluoxetin, paroxetin, bupropion, terbinafin)<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Sn\u00ed\u017een\u00e1 aktivace primachinu \u2192 sn\u00ed\u017een\u00e1 \u00fa\u010dinnost + riziko relapsu P. vivax<\/td>\n<td style=\"padding:8px;border-top:1px solid #e0e0e0;vertical-align:top;\">Pokud je to mo\u017en\u00e9, na\u010dasujte antimalarick\u00fd cyklus kolem antidepresiva; zva\u017ete vy\u0161\u0161\u00ed d\u00e1vku primachinu pod odborn\u00fdm dohledem.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2>Kontraindikace a upozorn\u011bn\u00ed<\/h2>\n<ul>\n<li><strong>Absolutn\u00ed kontraindikace:<\/strong> t\u011b\u017ek\u00fd deficit G6PD; t\u011bhotenstv\u00ed (stav G6PD plodu nezn\u00e1m\u00fd); aktivn\u00ed hemolytick\u00e1 an\u00e9mie; t\u011b\u017ek\u00e1 granulocytopenie; sou\u010dasn\u00e9 u\u017e\u00edv\u00e1n\u00ed chinakrinu.<\/li>\n<li><strong>Siln\u00e9 varov\u00e1n\u00ed:<\/strong> st\u0159edn\u011b t\u011b\u017ek\u00fd deficit G6PD (nutn\u00fd dohled specialisty); kojen\u00ed p\u0159ed z\u00edsk\u00e1n\u00edm v\u00fdsledku testu G6PD u d\u00edt\u011bte; t\u011b\u017ek\u00e1 revmatoidn\u00ed artritida nebo syst\u00e9mov\u00fd lupus erythematodes s l\u00e9ky potla\u010duj\u00edc\u00edmi kostn\u00ed d\u0159e\u0148.<\/li>\n<li><strong>Opatrn\u011b:<\/strong> deficit NADH cytochromu b5 redukt\u00e1zy (riziko methemoglobinemie); status \u0161patn\u00e9ho metaboliz\u00e1toru CYP2D6 (sn\u00ed\u017een\u00e1 \u00fa\u010dinnost).<\/li>\n<\/ul>\n<h2>Skladov\u00e1n\u00ed<\/h2>\n<p>Skladujte p\u0159i teplot\u011b do 25 \u00b0C na such\u00e9m m\u00edst\u011b v p\u016fvodn\u00edm obalu. Uchov\u00e1vejte mimo dosah d\u011bt\u00ed.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>Pro\u010d pot\u0159ebuji test G6PD p\u0159ed zah\u00e1jen\u00edm u\u017e\u00edv\u00e1n\u00ed Primaquinu?<\/h3>\n<p>Primaquin zp\u016fsobuje t\u011b\u017ekou akutn\u00ed hemolytickou an\u00e9mii u pacient\u016f s deficitem G6PD. Fluorescen\u010dn\u00ed spot test nebo kvantitativn\u00ed test aktivity G6PD jsou \u0161iroce dostupn\u00e9 a levn\u00e9. Prove\u010fte test p\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby; neza\u010d\u00ednejte s primaquinem za p\u0159edpokladu, \u017ee stav G6PD je norm\u00e1ln\u00ed.<\/p>\n<h3>Co je hypnozoit a pro\u010d na n\u011bm z\u00e1le\u017e\u00ed?<\/h3>\n<p>Paraziti P. vivax a P. ovale mohou p\u0159etrv\u00e1vat jako dormantn\u00ed formy v j\u00e1trech (hypnozoity) po t\u00fddny a\u017e m\u011bs\u00edce po po\u010d\u00e1te\u010dn\u00edm kousnut\u00ed. Standardn\u00ed antimalarika p\u016fsob\u00edc\u00ed na krevn\u00ed f\u00e1zi (chlorochin, ACT) hypnozoity nezab\u00edjej\u00ed. Bez radik\u00e1ln\u00ed l\u00e9\u010dby primaquinem se parazit reaktivuje a nov\u00e1 symptomatick\u00e1 infekce se objev\u00ed t\u00fddny a\u017e m\u011bs\u00edce pozd\u011bji. Primaquin je jedin\u00fd \u0161iroce dostupn\u00fd l\u00e9k, kter\u00fd hypnozoity ni\u010d\u00ed.<\/p>\n<h3>Pro\u010d 14denn\u00ed l\u00e9\u010dba?<\/h3>\n<p>Hypnozoity jsou biologicky odoln\u011bj\u0161\u00ed ve srovn\u00e1n\u00ed s parazity v krevn\u00ed f\u00e1zi. Krat\u0161\u00ed l\u00e9\u010debn\u00e9 re\u017eimy (3\u20137 dn\u00ed) maj\u00ed nep\u0159ijateln\u011b vysokou m\u00edru relaps\u016f. 14denn\u00ed l\u00e9\u010dba je minimem doporu\u010den\u00fdm WHO. Del\u0161\u00ed l\u00e9\u010debn\u00e9 re\u017eimy (21 dn\u00ed) se n\u011bkdy pou\u017e\u00edvaj\u00ed pro tropick\u00e9 kmeny P. vivax podobn\u00e9 \u201cChesson\u201d (Oce\u00e1nie, jihov\u00fdchodn\u00ed Asie, \u010d\u00e1sti Indie), kter\u00e9 jsou obzvl\u00e1\u0161t\u011b n\u00e1chyln\u00e9 k relaps\u016fm.<\/p>\n<h3>Lze Primaquin pou\u017e\u00edvat b\u011bhem t\u011bhotenstv\u00ed?<\/h3>\n<p>Ne. Primaquin je v t\u011bhotenstv\u00ed kontraindikov\u00e1n, proto\u017ee nelze testovat stav G6PD plodu in utero. Radik\u00e1ln\u00ed l\u00e9\u010dbu odlo\u017ete a\u017e po porodu a ukon\u010den\u00ed laktace. Potla\u010dte relapsy t\u00fddenn\u00ed profylax\u00ed chlorochinem (v oblastech citliv\u00fdch na chlorochin), dokud nebude mo\u017en\u00e9 prov\u00e9st radik\u00e1ln\u00ed l\u00e9\u010dbu.<\/p>\n<h3>A co kojen\u00ed?<\/h3>\n<p>Kompatibiln\u00ed, pokud jsou jak matka, tak d\u00edt\u011b potvrzeny jako G6PD-norm\u00e1ln\u00ed. Odlo\u017ete, dokud nebude zn\u00e1m stav G6PD u d\u00edt\u011bte.<\/p>\n<h3>Pro\u010d se n\u011bkdy pod\u00e1v\u00e1 primaquin spolu s chlorochinem?<\/h3>\n<p>Chlorochin odstra\u0148uje symptomatick\u00e9 st\u00e1dium v krvi; primaquin odstra\u0148uje dormantn\u00ed st\u00e1dium v j\u00e1trech. Spole\u010dn\u011b poskytuj\u00ed jak okam\u017eitou \u00falevu od p\u0159\u00edznak\u016f, tak radik\u00e1ln\u00ed l\u00e9\u010dbu. Nevynech\u00e1vejte ani jeden.<\/p>\n<h3>Co kdy\u017e vynech\u00e1m d\u00e1vku?<\/h3>\n<p>Vezm\u011bte ho, jakmile si vzpomenete, pokud nen\u00ed bl\u00edzko dal\u0161\u00ed d\u00e1vky. D\u016fsledn\u00e9 dodr\u017eov\u00e1n\u00ed v\u0161ech 14 dn\u016f je d\u016fle\u017eit\u00e9 \u2014 m\u00edra relaps\u016f prudce stoup\u00e1 s vynechan\u00fdmi d\u00e1vkami.<\/p>\n<h3>Funguje Primaquin na P. falciparum?<\/h3>\n<p>Ano, pro blokov\u00e1n\u00ed p\u0159enosu \u2014 jedin\u00e1 n\u00edzk\u00e1 d\u00e1vka (0,25 mg\/kg) s ACT odstran\u00ed gametocyty P. falciparum z krve a zabr\u00e1n\u00ed dal\u0161\u00edmu p\u0159enosu. Nen\u00ed pou\u017e\u00edv\u00e1n pro l\u00e9\u010dbu P. falciparum v konven\u010dn\u00edm smyslu \u2014 tuto roli pln\u00ed ACT.<\/p>\n<h3>Co je \u201cradik\u00e1ln\u00ed l\u00e9\u010dba\u201d vs \u201cl\u00e9\u010dba\u201d?<\/h3>\n<p>L\u00e9\u010dba = odstran\u011bn\u00ed symptomatick\u00e9 infekce v krevn\u00edm st\u00e1diu (chlorochin, ACT). Radik\u00e1ln\u00ed l\u00e9\u010dba = tak\u00e9 odstran\u011bn\u00ed dormantn\u00edch hypnozoit\u016f v jatern\u00edm st\u00e1diu u P. vivax \/ P. ovale, aby se zabr\u00e1nilo relapsu (primaquin nebo nov\u011bj\u0161\u00ed tafenoquin).<\/p>\n<h3>M\u016f\u017eu u\u017e\u00edvat Primaquin s alkoholem?<\/h3>\n<p>M\u00edrn\u00e1 konzumace alkoholu je p\u0159ijateln\u00e1. T\u011b\u017ek\u00e9 pit\u00ed m\u016f\u017ee zes\u00edlit gastrointestin\u00e1ln\u00ed pot\u00ed\u017ee a mal\u00e9 riziko hepatotoxicity. B\u011bhem 14denn\u00edho cyklu se vyhn\u011bte n\u00e1razov\u00e9mu pit\u00ed.<\/p>\n<h3>Pro\u010d je d\u00e1vka specifikov\u00e1na v \u201cb\u00e1zi\u201d?<\/h3>\n<p>Primaquin fosf\u00e1t je soln\u00e1 forma (stabiln\u011bj\u0161\u00ed). D\u00e1vky v klinick\u00fdch referenc\u00edch jsou uv\u00e1d\u011bny v primaquin b\u00e1zi. Standardn\u00ed tableta 15 mg je ozna\u010dena jako \u201c15 mg b\u00e1ze\u201d \u2014 skute\u010dn\u00fd obsah fosf\u00e1tov\u00e9 soli na tabletu je ~ 26 mg. V\u017edy si ov\u011b\u0159te, zda je uvedeno \u201cb\u00e1ze\u201d nebo \u201cfosf\u00e1t\u201d p\u0159i v\u00fdpo\u010dtech d\u00e1vek.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Dal\u0161\u00ed tablety proti mal\u00e1rii<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/lariago\/\"><strong>Lariago 250 mg<\/strong><\/a> \u2014 Chlorochin \u2014 zab\u00edj\u00ed parazity v krevn\u00edm st\u00e1diu; primaquin je pak pot\u0159eba pro radik\u00e1ln\u00ed l\u00e9\u010dbu jatern\u00edho st\u00e1dia<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/mefque\/\"><strong>Mefque 250 mg<\/strong><\/a> \u2014 Mefloquine \u2014 jednou t\u00fddn\u011b chemoprofylaxe pro oblasti rezistentn\u00ed na chlorochin<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/cendox\/\"><strong>Cendox 100 mg<\/strong><\/a> \u2014 Doxycyklin \u2014 denn\u00ed profylaxe pro rezistentn\u00ed oblasti + dopln\u011bk radik\u00e1ln\u00ed l\u00e9\u010dby<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hcqs\/\"><strong>HCQS 200\/400 mg<\/strong><\/a> \u2014 Hydroxychloroquine \u2014 antimalarikum + indikace u autoimunitn\u00edch onemocn\u011bn\u00ed<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/quinin-300\/\"><strong>Quinin 300 mg<\/strong><\/a> \u2014 Chinin \u2014 vybran\u00e9 pou\u017eit\u00ed u chlorochin-rezistentn\u00ed P. falciparum<\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:24px 0;font-size:13px;line-height:1.6;\"><strong>Zdravotn\u00ed prohl\u00e1\u0161en\u00ed.<\/strong> Tato str\u00e1nka obsahuje pouze obecn\u00e9 informace a nenahrazuje poradenstv\u00ed v cestovn\u00ed medic\u00edn\u011b ani l\u00e9\u010dbu pod dohledem l\u00e9ka\u0159e. Rezistence na l\u00e9ky se m\u011bn\u00ed podle destinace \u2014 p\u0159ed cestou potvr\u010fte volbu profylaxe podle aktu\u00e1ln\u00edch <a href=\"https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2024\/preparing\/malaria\" rel=\"nofollow noopener\" target=\"_blank\">CDC Yellow Book<\/a> nebo <a href=\"https:\/\/www.fitfortravel.nhs.uk\/destinations\" rel=\"nofollow noopener\" target=\"_blank\">fitfortravel.nhs.uk<\/a> doporu\u010den\u00ed. Jak\u00e9koli hore\u010dnat\u00e9 onemocn\u011bn\u00ed do 1 roku po n\u00e1vratu z oblasti endemick\u00e9 mal\u00e1rie vy\u017eaduje urgentn\u00ed vy\u0161et\u0159en\u00ed tlustou a tenkou kapkou krve. T\u011b\u017ek\u00e1 mal\u00e1rie (porucha v\u011bdom\u00ed, \u017eloutenka, hypoglyk\u00e9mie, du\u0161nost) je stav vy\u017eaduj\u00edc\u00ed neodkladnou hospitalizaci.<\/div>","protected":false},"excerpt":{"rendered":"<p>\u2705 L\u00e9\u010dba mal\u00e1rie<br \/>\n\u2705 Zabra\u0148uje relapsu<br \/>\n\u2705 Eliminuje parazity<br \/>\n\u2705 Zastavuje p\u0159enos<br \/>\n\u2705 Zkracuje d\u00e9lku onemocn\u011bn\u00ed<\/p>\n<p>Primaquin obsahuje Primaquin Phosphate.<\/p>","protected":false},"featured_media":60222,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3580,3448],"product_tag":[4824,4825],"class_list":{"0":"post-60221","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-malaria-tablets","8":"product_cat-travel-health-category-overview","9":"product_tag-primaquine","10":"product_tag-primaquine-phosphate","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/60221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=60221"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/60222"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=60221"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=60221"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=60221"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=60221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}